UTMD
Utah Medical Products Inc
73.50$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.1% | 42.4% | 40.3% | 44.8% | 47.3% | 41.9% | 43.0% | 49.2% | 48.4% | 47.7% | 39.4% | 44.4% | 45.1% | |
| 45.9% | 57.6% | 59.7% | 55.2% | 52.7% | 58.1% | 57.0% | 50.8% | 51.6% | 52.3% | 60.6% | 55.6% | 54.9% | |
| 1.1% | 1.2% | 2.3% | 2.5% | 1.7% | 1.3% | 1.6% | 1.4% | 1.7% | 2.3% | 1.8% | 1.8% | 1.9% | |
| 22.7% | 75.9% | 8.4% | 19.4% | 7.4% | 62.2% | 9.4% | 22.7% | 28.8% | 28.9% | 19.1% | 22.9% | 25.1% | |
| 14.2% | 25.6% | 25.4% | 22.2% | 19.3% | 26.1% | 24.6% | 18.7% | 25.0% | 25.3% | 31.2% | 24.4% | 26.4% | |
| 31.7% | 32.0% | 34.2% | 33.1% | 33.4% | 32.0% | 32.5% | 32.1% | 26.6% | 27.0% | 29.4% | 31.2% | 28.5% | |
| – | 14.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 38.2% | 40.7% | 42.3% | 40.5% | 41.8% | 39.5% | 39.7% | 38.5% | 33.7% | 34.3% | 36.5% | 38.5% | 35.7% | |
| 6.8% | 5.9% | 7.4% | 7.3% | 6.2% | 7.8% | 8.4% | 7.9% | 6.9% | 6.0% | 6.6% | 7.0% | 6.6% | |
| 31.5% | 34.8% | 34.9% | 33.2% | 35.6% | 31.7% | 31.3% | 30.6% | 26.8% | 28.4% | 29.9% | 31.5% | 29.0% | |
| 52.5% | 45.6% | 46.9% | 47.2% | 49.2% | 43.5% | 43.1% | 46.0% | 41.6% | 42.7% | 44.4% | 34.0% | 40.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.